Keep Me Logged In
Gilead Sciences is reporting Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with CNBC's Meg Tirrell. Sales of Sovaldi during the second quarter came in at $3.48 billion.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by